Submission of Matters to a Vote of Security Holders.
Spectrum Pharmaceuticals, Inc. (the 'Company') held its 2021 annual meeting of stockholders (the 'Annual Meeting') on June 17, 2021 at the Company's corporate headquarters located at 11500 S. Eastern Avenue, Suite 240, Henderson, Nevada 89052. As of the close of business on April 20, 2021, the record date for the Annual Meeting, a total of 155,713,230 shares were outstanding and entitled to vote, of which a total of 106,681,573 shares were present in person or by proxy at the Annual Meeting, constituting a quorum for the conduct of business thereat.
The following sets forth detailed information regarding the voting results at the Annual Meeting for each of the matters voted upon by the stockholders. These matters are described in more detail in the Company's Definitive Proxy Statement for its Annual Meeting of Stockholders filed with the Securities and Exchange Commission on April 21, 2021 (the 'Proxy Statement').
Proposal No. 1:
The Company's stockholders elected each of the seven nominees named below to serve on the Board of Directors of the Company for a one-year term expiring at the annual meeting of stockholders in 2022 and until their respective successors are duly elected and qualified, or until their earlier resignation or removal.
|
Nominee
|
Votes For
|
Votes Against
|
Abstentions
|
Broker Non-Votes
|
William L. Ashton
|
83,591,525
|
2,264,965
|
457,988
|
20,367,095
|
Nora E. Brennan
|
84,250,330
|
1,637,135
|
427,013
|
20,367,095
|
Seth H.Z. Fischer
|
83,679,081
|
2,185,138
|
450,259
|
20,367,095
|
Joseph W. Turgeon
|
84,018,497
|
1,866,293
|
429,688
|
20,367,095
|
Jeffrey L. Vacirca, M.D., FACP
|
83,048,340
|
2,782,897
|
483,241
|
20,367,095
|
Dolatrai M. Vyas, Ph.D.
|
83,565,401
|
2,297,537
|
451,540
|
20,367,095
|
Bernice R. Welles, M.D., M.B.A.
|
83,002,308
|
2,884,751
|
427,419
|
20,367,095
|
Proposal No. 2:
The Company's stockholders approved by advisory vote the compensation of the Company's named executive officers, as disclosed in the Compensation Discussion and Analysis section of the Proxy Statement.
|
Votes For
|
Votes Against
|
Abstentions
|
Broker Non-Votes
|
81,208,187
|
4,439,741
|
666,550
|
20,367,095
|
Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description
104 Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL)